Advertisement
U.S. markets closed

Forte Biosciences, Inc. (FBRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.6962+0.0013 (+0.19%)
At close: 04:00PM EDT
0.7000 +0.00 (+0.55%)
After hours: 05:05PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Inside Bar (Bearish)

Inside Bar (Bearish)

Previous Close0.6949
Open0.6950
Bid0.7000 x 1100
Ask0.7600 x 1000
Day's Range0.6717 - 0.7390
52 Week Range0.3800 - 1.2900
Volume52,238
Avg. Volume34,783
Market Cap25.338M
Beta (5Y Monthly)1.65
PE Ratio (TTM)N/A
EPS (TTM)-1.0000
Earnings DateMay 13, 2024 - May 17, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for FBRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Forte Biosciences, Inc.
    Technical Assessment: Neutral in the Intermediate-TermWas that a case of quarter-end buying by institutions? Over the last 50 minutes of the trading session on Wednesday, the S&P 500 (SPX) took off like a rocket, surging 30 points and finishing 0.9% higher on the day and at another all-time high. But the biggest winners on the day were small-caps, with the Russell 2000 (IWM) surging 2.2% and the S&P 600 (SML) spiking 2.4%. The IWM is breaking out of a more-than two-year base and closed at its highest level since December 2021.
    Rating
    Fair Value
    Economic Moat
    22 hours agoArgus Research
View more